Cannabis operator Flora Growth Corp. on Wednesday announced an agreement with London-based Blossom Genetics to supply medical cannabis to the German market.
Financial details of the partnership were not disclosed.
ADVERTISEMENT
Under the deal, the duo plans to introduce two flower strains – Chemmy Jones and Northern Lights – in Germany, which enacted a landmark recreational cannabis law on April 1.
The legislation that ushered in a limited recreational market essentially decriminalized cannabis, allowed home grows and laid the framework to establish “cultivation social clubs” – nonprofit organizations where members can acquire marijuana for adult use.
“This supply agreement with Blossom Genetics is a pivotal step in our efforts to expand Flora’s global presence and provide top-tier cannabis products to Germany,” Chairman and CEO Clifford
Read full article on Marijuana Business Daily
